ARCHIVES

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Low Prevalence Of Tamoxifen Use For Cancer Prevention

February 26, 2010

Tumors Harder To Detect In Women In Their Forties

August 27, 2010

Program Announcements, RFA In Radiation Effects Available

September 24, 1982

NCI considers allowing some centers to opt out of site visits.

March 19, 2004

SAIC-Frederick Makes Awards To Proteomics Research Teams.

January 14, 2005

WHT Participants Get “Phase Out” Help

March 11, 1988